logo-loader
viewNetscientific PLC

NetScientific gaining critical mass with commercial ramp-up of portfolio

Francois Martelet, chief executive of NetScientific PLC (LON:NSCI), caught up with Proactive's Andrew Scott to update on developments within the IP commercialisation specialist's portfolio.

''All of our companies are game-changing and unique in their sectors'', Martelet says.

Most recently NetScientific announced the issue by the US Patent and Trademark Office of two new patents exclusively licensed to their portfolio company, Wanda.

The patents will significantly extend protection for the core technology used in Wanda's software application for remote health and patient management.

Quick facts: Netscientific PLC

Price: 6 GBX

AIM:NSCI
Market: AIM
Market Cap: £4.71 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Netscientific PLC named herein, including the promotion by the Company of Netscientific PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: ANGLE reports positive data from Parsortix FDA clinical study

Top stories from the Proactive Investors UK newsroom: ANGLE PLC (LON:AGL) has received positive results from its Parsortix FDA clinical study for metastatic breast cancer. The 400-subject clinical study will support an application for Class II regulatory clearance for Parsortix in the...

on 31/5/19

2 min read